Title: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer

December 15, 2020 at 1:45 PM


  • Jonathan Ledermann, MD, FRCP, UCL Cancer Institute, U.K.
  • Alexandra Leary, MD, PhD, Gustave Roussy Institute of Oncology, France
  • Frederik Marmé, MD PhD, University of Heidelberg, Germany



  • Genetic drivers of ovarian cancer development – Dr. Leary
  • Comparison of pharmacologic properties of approved and investigational PARP inhibitors  - Dr. Marmé
  • PARP inhibitors in recurrent ovarian cancer – Dr. Ledermann
  • Ongoing research with PARP inhibitors – panel discussion